Performance of the Water-Enema Computed Tomography (WE-CT)

NCT ID: NCT00188110

Last Updated: 2007-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The WE-CT is an innovative and easy practice imaging technique of colon tumors; it is based on the colon distension by a high volume of warm water and a multidetector CT acquisition after IV (intravenous) contrast, allowing image analysis including the wall thickness and enhancement, the pericolic adjacent spaces and the entire abdomen.

The goal of the study is the evaluation of its performances for the diagnosis of colon tumors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colon Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Water-Enema Computed Tomography

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written informed consent
* WE-TC indication for colon tumor suspicion
* Age \> 18 years

Exclusion Criteria

* Pregnancy
* Patients under 65 years old and for whom the only WE-TC indication is familial antecedents of colon tumor, without clinical or para-clinical personal signs for this pathology
* Infected sigmoid diverticulosis
* Occlusive syndrome
* Anesthesia contraindications
* Anal incontinence
* Renal insufficiency (creatinine \> 150 micromol/L)
* Iode allergy
* Visceralgine contraindications
* Scania contraindications
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Health, France

OTHER_GOV

Sponsor Role collaborator

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christophe Aube, MD

Role: PRINCIPAL_INVESTIGATOR

UH of Angers

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UH of Angers

Angers, , France

Site Status RECRUITING

UH of Besancon

Besançon, , France

Site Status ACTIVE_NOT_RECRUITING

UH of Lyon

Lyon, , France

Site Status RECRUITING

UH of Montpellier

Montpellier, , France

Site Status ACTIVE_NOT_RECRUITING

UH of Rennes

Rennes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christophe Aube, MD

Role: CONTACT

00-2-41-35-42-76

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christophe Aube, MD

Role: primary

00-2-41-35-42-76

Jean Valette, MD

Role: primary

00-4-72-11-75-40

Yves Gandon, MD

Role: primary

00-2-99-28-43-67

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2002/23 (CCPPRB)

Identifier Type: -

Identifier Source: secondary_id

PHRC-02-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MR Urography vs CT Urography
NCT02606513 COMPLETED NA